| Willapa Harbor Hospital | |
| 800 Alder Street, South Bend, Washington 98586 | |
| (360) 875-5526 | |
| Name | Willapa Harbor Hospital |
|---|---|
| Type | Critical Access Hospital |
| Location | 800 Alder Street, South Bend, Washington |
| Ownership | Government - Hospital District or Authority |
| Emergency Services | Yes |
| Medicare ID (CCN) | 501303 |
| NPI Number | 1295708683 |
| Organization Name | PACIFIC COUNTY HOSPITAL DISTRICT 2 |
| Doing Business As | WILLAPA HARBOR HOSPITAL |
| Address | 800 Alder St, South Bend, WA 98586 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 360-875-5526 |
News Archive
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 5 of its newsletter, the "Global Fund News Flash."
Urinary catheters are often left in place longer than needed, and new research shows that reminder systems that encourage hospital staff to remove catheters promptly can reduce the rate of catheter-associated urinary tract infections by 52 percent.
Par Pharmaceutical Companies, Inc. today announced that it (and its subsidiary Par Pharmaceutical and development partner MN Pharmaceuticals of Turkey) has entered into a settlement agreement with sanofi-aventis that resolves patent litigation related to its generic version of sanofi's and Debiopharm's Eloxatin® (oxaliplatin injection) product, a drug used to treat colorectal cancer, in the U.S. District Court for the District of New Jersey.
Hot on the heels of discovering a protective form of immune response to spinal cord injury, researchers at the University of Virginia School of Medicine have pinpointed the biological trigger for that response - a vital step toward being able to harness the body's defenses to improve treatment for spine injuries, brain trauma, Alzheimer's disease and other neurodegenerative conditions.
› Verified 4 days ago
| NPI Number | 1508939513 |
| Organization Name | PACIFIC COUNTY PUBLIC HOSPITAL DISTRICT # 2 |
| Address | 800 Alder St, South Bend, WA 98586 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 360-875-5526 |
News Archive
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 5 of its newsletter, the "Global Fund News Flash."
Urinary catheters are often left in place longer than needed, and new research shows that reminder systems that encourage hospital staff to remove catheters promptly can reduce the rate of catheter-associated urinary tract infections by 52 percent.
Par Pharmaceutical Companies, Inc. today announced that it (and its subsidiary Par Pharmaceutical and development partner MN Pharmaceuticals of Turkey) has entered into a settlement agreement with sanofi-aventis that resolves patent litigation related to its generic version of sanofi's and Debiopharm's Eloxatin® (oxaliplatin injection) product, a drug used to treat colorectal cancer, in the U.S. District Court for the District of New Jersey.
Hot on the heels of discovering a protective form of immune response to spinal cord injury, researchers at the University of Virginia School of Medicine have pinpointed the biological trigger for that response - a vital step toward being able to harness the body's defenses to improve treatment for spine injuries, brain trauma, Alzheimer's disease and other neurodegenerative conditions.
› Verified 4 days ago
| NPI Number | 1982938619 |
| Organization Name | PACIFIC COUNTY HOSPITAL DISTRICT 2 |
| Doing Business As | WILLAPA HARBOR HOSPITAL PHYSICIAN GROUP |
| Address | 800 Alder St, South Bend, WA 98586 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 360-875-5526 |
News Archive
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 5 of its newsletter, the "Global Fund News Flash."
Urinary catheters are often left in place longer than needed, and new research shows that reminder systems that encourage hospital staff to remove catheters promptly can reduce the rate of catheter-associated urinary tract infections by 52 percent.
Par Pharmaceutical Companies, Inc. today announced that it (and its subsidiary Par Pharmaceutical and development partner MN Pharmaceuticals of Turkey) has entered into a settlement agreement with sanofi-aventis that resolves patent litigation related to its generic version of sanofi's and Debiopharm's Eloxatin® (oxaliplatin injection) product, a drug used to treat colorectal cancer, in the U.S. District Court for the District of New Jersey.
Hot on the heels of discovering a protective form of immune response to spinal cord injury, researchers at the University of Virginia School of Medicine have pinpointed the biological trigger for that response - a vital step toward being able to harness the body's defenses to improve treatment for spine injuries, brain trauma, Alzheimer's disease and other neurodegenerative conditions.
› Verified 4 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 5 of its newsletter, the "Global Fund News Flash."
Urinary catheters are often left in place longer than needed, and new research shows that reminder systems that encourage hospital staff to remove catheters promptly can reduce the rate of catheter-associated urinary tract infections by 52 percent.
Par Pharmaceutical Companies, Inc. today announced that it (and its subsidiary Par Pharmaceutical and development partner MN Pharmaceuticals of Turkey) has entered into a settlement agreement with sanofi-aventis that resolves patent litigation related to its generic version of sanofi's and Debiopharm's Eloxatin® (oxaliplatin injection) product, a drug used to treat colorectal cancer, in the U.S. District Court for the District of New Jersey.
Hot on the heels of discovering a protective form of immune response to spinal cord injury, researchers at the University of Virginia School of Medicine have pinpointed the biological trigger for that response - a vital step toward being able to harness the body's defenses to improve treatment for spine injuries, brain trauma, Alzheimer's disease and other neurodegenerative conditions.
› Verified 4 days ago
Willapa Harbor Hospital Critical Access Hospital Location: 800 Alder Street, South Bend, Washington 98586 Phone: (360) 875-5526 |